News & Updates
FDA Grants Breakthrough Device Designation to Metabiomics Test for the Early Detection of Colon Polyps and Colon Cancer
September 4, 2019 — This Breakthrough Device designation is the first designation for a non-invasive diagnostic test that is designed to detect pre-cancerous polyps, as well as early-stage carcinomas.
Prescient Medicine Holdings Inc. Acquires AutoGenomics Inc.
April 23, 2019 — The acquisition of AutoGenomics will enable Prescient Medicine to advance the development and commercialization of a novel diagnostic test for the identification of patients who may be at risk for opioid use disorder (OUD).